Robert Wakolbinger-Habel, Matthias Reinweber, Mahmoud Alakraa, Ingrid Riener, Brigitte Elisabeth Scheffold, Krisztina Racz, Flonza Selimi, Claudia Straub, Jakob Jauker, Walter Bily, Dora Niedersüß-Beke, Karl Mayrhofer, Tatjana Paternostro-Sluga
BACKGROUND: Most oncologic patients receiving chemotherapy suffer from neuropathy, which not only severely affects quality of life but also may lead to chemotherapy dose reductions or even discontinuation of cancer therapy. Still, it is difficult to sufficiently control these symptoms with the currently available pharmacological treatments. High tone therapy was reported to be an effective option for neuropathies due to different etiologies. However, to date, there are no studies on high tone therapy in patients with chemotherapy-induced peripheral neuropathy...
January 27, 2024: Supportive Care in Cancer